Clinical trial
Effectiveness and Safety of Intra-arterial Tenecteplase Bridging Therapy Following Incomplete Recanalization After Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
NCT07471282 is registered in ClinicalTrials.gov with Chuansheng Zhao as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Safety of Intra-arterial Tenecteplase Bridging Therapy Following Incomplete Recanalization After Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion: A Prospective, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
- Lead sponsor
- Chuansheng Zhao
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- March 1, 2026
- Completion date
- March 31, 2029
- Enrollment
- 344 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.